English
简体中文
Total: £ 56.28
Published Date: 2024-10-17 | Pages: 146 | Tables: 249 | Pharma & Healthcare
Complementary therapy for prevention and treatment of hemophilia A acquired coagulation factor Ⅷ deficiency and von Willebrand's disease
The global market for Human Factor VIII Concentrate was estimated to be worth US$ 185 million in 2023 and is forecast to a readjusted size of US$ 242.9 million by 2030 with a CAGR of 4.0% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Factor VIII Concentrate, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Human Factor VIII Concentrate by region & country, by Type, and by Application.
The Human Factor VIII Concentrate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Factor VIII Concentrate.
Market Segmentation
By Company
Pfizer
Novo Nordisk A/S
Shire (Baxter)
Bayer
GC Pharma
Shanghai Raas Corp
Hualan Biological
Shandong Taibang Biological Products
Shanghai Xinxing Medicine
SinoCell Tech
CSL
Grifols
Biogen
Octapharma
NovoNordisk
Segment by Type:
Blood Extraction
Recombine
Segment by Application
Congenital Coagulation Factor VIII Deficiency
Acquired Factor VIII Deficiency
Von Willebrand's Disease
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Human Factor VIII Concentrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Human Factor VIII Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Human Factor VIII Concentrate in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Human Factor VIII Concentrate Product Introduction
1.2 Global Human Factor VIII Concentrate Market Size Forecast
1.2.1 Global Human Factor VIII Concentrate Sales Value (2019-2030)
1.2.2 Global Human Factor VIII Concentrate Sales Volume (2019-2030)
1.2.3 Global Human Factor VIII Concentrate Sales Price (2019-2030)
1.3 Human Factor VIII Concentrate Market Trends & Drivers
1.3.1 Human Factor VIII Concentrate Industry Trends
1.3.2 Human Factor VIII Concentrate Market Drivers & Opportunity
1.3.3 Human Factor VIII Concentrate Market Challenges
1.3.4 Human Factor VIII Concentrate Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human Factor VIII Concentrate Players Revenue Ranking (2023)
2.2 Global Human Factor VIII Concentrate Revenue by Company (2019-2024)
2.3 Global Human Factor VIII Concentrate Players Sales Volume Ranking (2023)
2.4 Global Human Factor VIII Concentrate Sales Volume by Company Players (2019-2024)
2.5 Global Human Factor VIII Concentrate Average Price by Company (2019-2024)
2.6 Key Manufacturers Human Factor VIII Concentrate Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Human Factor VIII Concentrate Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Human Factor VIII Concentrate
2.9 Human Factor VIII Concentrate Market Competitive Analysis
2.9.1 Human Factor VIII Concentrate Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Human Factor VIII Concentrate Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Factor VIII Concentrate as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Blood Extraction
3.1.2 Recombine
3.2 Global Human Factor VIII Concentrate Sales Value by Type
3.2.1 Global Human Factor VIII Concentrate Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Human Factor VIII Concentrate Sales Value, by Type (2019-2030)
3.2.3 Global Human Factor VIII Concentrate Sales Value, by Type (%) (2019-2030)
3.3 Global Human Factor VIII Concentrate Sales Volume by Type
3.3.1 Global Human Factor VIII Concentrate Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Human Factor VIII Concentrate Sales Volume, by Type (2019-2030)
3.3.3 Global Human Factor VIII Concentrate Sales Volume, by Type (%) (2019-2030)
3.4 Global Human Factor VIII Concentrate Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Congenital Coagulation Factor VIII Deficiency
4.1.2 Acquired Factor VIII Deficiency
4.1.3 Von Willebrand's Disease
4.2 Global Human Factor VIII Concentrate Sales Value by Application
4.2.1 Global Human Factor VIII Concentrate Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Human Factor VIII Concentrate Sales Value, by Application (2019-2030)
4.2.3 Global Human Factor VIII Concentrate Sales Value, by Application (%) (2019-2030)
4.3 Global Human Factor VIII Concentrate Sales Volume by Application
4.3.1 Global Human Factor VIII Concentrate Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Human Factor VIII Concentrate Sales Volume, by Application (2019-2030)
4.3.3 Global Human Factor VIII Concentrate Sales Volume, by Application (%) (2019-2030)
4.4 Global Human Factor VIII Concentrate Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Human Factor VIII Concentrate Sales Value by Region
5.1.1 Global Human Factor VIII Concentrate Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Human Factor VIII Concentrate Sales Value by Region (2019-2024)
5.1.3 Global Human Factor VIII Concentrate Sales Value by Region (2025-2030)
5.1.4 Global Human Factor VIII Concentrate Sales Value by Region (%), (2019-2030)
5.2 Global Human Factor VIII Concentrate Sales Volume by Region
5.2.1 Global Human Factor VIII Concentrate Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Human Factor VIII Concentrate Sales Volume by Region (2019-2024)
5.2.3 Global Human Factor VIII Concentrate Sales Volume by Region (2025-2030)
5.2.4 Global Human Factor VIII Concentrate Sales Volume by Region (%), (2019-2030)
5.3 Global Human Factor VIII Concentrate Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Human Factor VIII Concentrate Sales Value, 2019-2030
5.4.2 North America Human Factor VIII Concentrate Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Human Factor VIII Concentrate Sales Value, 2019-2030
5.5.2 Europe Human Factor VIII Concentrate Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Human Factor VIII Concentrate Sales Value, 2019-2030
5.6.2 Asia Pacific Human Factor VIII Concentrate Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Human Factor VIII Concentrate Sales Value, 2019-2030
5.7.2 South America Human Factor VIII Concentrate Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Human Factor VIII Concentrate Sales Value, 2019-2030
5.8.2 Middle East & Africa Human Factor VIII Concentrate Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human Factor VIII Concentrate Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Human Factor VIII Concentrate Sales Value
6.2.1 Key Countries/Regions Human Factor VIII Concentrate Sales Value, 2019-2030
6.2.2 Key Countries/Regions Human Factor VIII Concentrate Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Human Factor VIII Concentrate Sales Value, 2019-2030
6.3.2 United States Human Factor VIII Concentrate Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Human Factor VIII Concentrate Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Human Factor VIII Concentrate Sales Value, 2019-2030
6.4.2 Europe Human Factor VIII Concentrate Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Human Factor VIII Concentrate Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Human Factor VIII Concentrate Sales Value, 2019-2030
6.5.2 China Human Factor VIII Concentrate Sales Value by Type (%), 2023 VS 2030
6.5.3 China Human Factor VIII Concentrate Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Human Factor VIII Concentrate Sales Value, 2019-2030
6.6.2 Japan Human Factor VIII Concentrate Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Human Factor VIII Concentrate Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Human Factor VIII Concentrate Sales Value, 2019-2030
6.7.2 South Korea Human Factor VIII Concentrate Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Human Factor VIII Concentrate Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Human Factor VIII Concentrate Sales Value, 2019-2030
6.8.2 Southeast Asia Human Factor VIII Concentrate Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Human Factor VIII Concentrate Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Human Factor VIII Concentrate Sales Value, 2019-2030
6.9.2 India Human Factor VIII Concentrate Sales Value by Type (%), 2023 VS 2030
6.9.3 India Human Factor VIII Concentrate Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Introduction and Business Overview
7.1.3 Pfizer Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pfizer Human Factor VIII Concentrate Product Offerings
7.1.5 Pfizer Recent Development
7.2 Novo Nordisk A/S
7.2.1 Novo Nordisk A/S Company Information
7.2.2 Novo Nordisk A/S Introduction and Business Overview
7.2.3 Novo Nordisk A/S Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Novo Nordisk A/S Human Factor VIII Concentrate Product Offerings
7.2.5 Novo Nordisk A/S Recent Development
7.3 Shire (Baxter)
7.3.1 Shire (Baxter) Company Information
7.3.2 Shire (Baxter) Introduction and Business Overview
7.3.3 Shire (Baxter) Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Shire (Baxter) Human Factor VIII Concentrate Product Offerings
7.3.5 Shire (Baxter) Recent Development
7.4 Bayer
7.4.1 Bayer Company Information
7.4.2 Bayer Introduction and Business Overview
7.4.3 Bayer Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Bayer Human Factor VIII Concentrate Product Offerings
7.4.5 Bayer Recent Development
7.5 GC Pharma
7.5.1 GC Pharma Company Information
7.5.2 GC Pharma Introduction and Business Overview
7.5.3 GC Pharma Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.5.4 GC Pharma Human Factor VIII Concentrate Product Offerings
7.5.5 GC Pharma Recent Development
7.6 Shanghai Raas Corp
7.6.1 Shanghai Raas Corp Company Information
7.6.2 Shanghai Raas Corp Introduction and Business Overview
7.6.3 Shanghai Raas Corp Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Shanghai Raas Corp Human Factor VIII Concentrate Product Offerings
7.6.5 Shanghai Raas Corp Recent Development
7.7 Hualan Biological
7.7.1 Hualan Biological Company Information
7.7.2 Hualan Biological Introduction and Business Overview
7.7.3 Hualan Biological Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Hualan Biological Human Factor VIII Concentrate Product Offerings
7.7.5 Hualan Biological Recent Development
7.8 Shandong Taibang Biological Products
7.8.1 Shandong Taibang Biological Products Company Information
7.8.2 Shandong Taibang Biological Products Introduction and Business Overview
7.8.3 Shandong Taibang Biological Products Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Shandong Taibang Biological Products Human Factor VIII Concentrate Product Offerings
7.8.5 Shandong Taibang Biological Products Recent Development
7.9 Shanghai Xinxing Medicine
7.9.1 Shanghai Xinxing Medicine Company Information
7.9.2 Shanghai Xinxing Medicine Introduction and Business Overview
7.9.3 Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Shanghai Xinxing Medicine Human Factor VIII Concentrate Product Offerings
7.9.5 Shanghai Xinxing Medicine Recent Development
7.10 SinoCell Tech
7.10.1 SinoCell Tech Company Information
7.10.2 SinoCell Tech Introduction and Business Overview
7.10.3 SinoCell Tech Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.10.4 SinoCell Tech Human Factor VIII Concentrate Product Offerings
7.10.5 SinoCell Tech Recent Development
7.11 CSL
7.11.1 CSL Company Information
7.11.2 CSL Introduction and Business Overview
7.11.3 CSL Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.11.4 CSL Human Factor VIII Concentrate Product Offerings
7.11.5 CSL Recent Development
7.12 Grifols
7.12.1 Grifols Company Information
7.12.2 Grifols Introduction and Business Overview
7.12.3 Grifols Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Grifols Human Factor VIII Concentrate Product Offerings
7.12.5 Grifols Recent Development
7.13 Biogen
7.13.1 Biogen Company Information
7.13.2 Biogen Introduction and Business Overview
7.13.3 Biogen Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Biogen Human Factor VIII Concentrate Product Offerings
7.13.5 Biogen Recent Development
7.14 Octapharma
7.14.1 Octapharma Company Information
7.14.2 Octapharma Introduction and Business Overview
7.14.3 Octapharma Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Octapharma Human Factor VIII Concentrate Product Offerings
7.14.5 Octapharma Recent Development
7.15 NovoNordisk
7.15.1 NovoNordisk Company Information
7.15.2 NovoNordisk Introduction and Business Overview
7.15.3 NovoNordisk Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2019-2024)
7.15.4 NovoNordisk Human Factor VIII Concentrate Product Offerings
7.15.5 NovoNordisk Recent Development
8 Industry Chain Analysis
8.1 Human Factor VIII Concentrate Industrial Chain
8.2 Human Factor VIII Concentrate Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Human Factor VIII Concentrate Sales Model
8.5.2 Sales Channel
8.5.3 Human Factor VIII Concentrate Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Human Factor VIII Concentrate Market Trends
Table 2. Human Factor VIII Concentrate Market Drivers & Opportunity
Table 3. Human Factor VIII Concentrate Market Challenges
Table 4. Human Factor VIII Concentrate Market Restraints
Table 5. Global Human Factor VIII Concentrate Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Human Factor VIII Concentrate Revenue Market Share by Company (2019-2024)
Table 7. Global Human Factor VIII Concentrate Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Human Factor VIII Concentrate Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Human Factor VIII Concentrate Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Human Factor VIII Concentrate Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Human Factor VIII Concentrate Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Human Factor VIII Concentrate
Table 13. Global Human Factor VIII Concentrate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Factor VIII Concentrate as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Factor VIII Concentrate Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Human Factor VIII Concentrate Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Human Factor VIII Concentrate Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Human Factor VIII Concentrate Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Human Factor VIII Concentrate Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Human Factor VIII Concentrate Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Human Factor VIII Concentrate Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Human Factor VIII Concentrate Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Human Factor VIII Concentrate Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Human Factor VIII Concentrate Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Human Factor VIII Concentrate Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Human Factor VIII Concentrate Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Human Factor VIII Concentrate Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Human Factor VIII Concentrate Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Human Factor VIII Concentrate Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Human Factor VIII Concentrate Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Human Factor VIII Concentrate Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Human Factor VIII Concentrate Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Human Factor VIII Concentrate Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Human Factor VIII Concentrate Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Human Factor VIII Concentrate Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Human Factor VIII Concentrate Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Human Factor VIII Concentrate Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Human Factor VIII Concentrate Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Human Factor VIII Concentrate Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Human Factor VIII Concentrate Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Human Factor VIII Concentrate Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Human Factor VIII Concentrate Sales Value by Region (2019-2024) & (%)
Table 44. Global Human Factor VIII Concentrate Sales Value by Region (2025-2030) & (%)
Table 45. Global Human Factor VIII Concentrate Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Human Factor VIII Concentrate Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Human Factor VIII Concentrate Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Human Factor VIII Concentrate Sales Volume by Region (2019-2024) & (%)
Table 49. Global Human Factor VIII Concentrate Sales Volume by Region (2025-2030) & (%)
Table 50. Global Human Factor VIII Concentrate Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Human Factor VIII Concentrate Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Human Factor VIII Concentrate Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Human Factor VIII Concentrate Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Human Factor VIII Concentrate Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Human Factor VIII Concentrate Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Human Factor VIII Concentrate Sales Volume, (2025-2030) & (K Units)
Table 57. Pfizer Company Information
Table 58. Pfizer Introduction and Business Overview
Table 59. Pfizer Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Pfizer Human Factor VIII Concentrate Product Offerings
Table 61. Pfizer Recent Development
Table 62. Novo Nordisk A/S Company Information
Table 63. Novo Nordisk A/S Introduction and Business Overview
Table 64. Novo Nordisk A/S Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Novo Nordisk A/S Human Factor VIII Concentrate Product Offerings
Table 66. Novo Nordisk A/S Recent Development
Table 67. Shire (Baxter) Company Information
Table 68. Shire (Baxter) Introduction and Business Overview
Table 69. Shire (Baxter) Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Shire (Baxter) Human Factor VIII Concentrate Product Offerings
Table 71. Shire (Baxter) Recent Development
Table 72. Bayer Company Information
Table 73. Bayer Introduction and Business Overview
Table 74. Bayer Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Bayer Human Factor VIII Concentrate Product Offerings
Table 76. Bayer Recent Development
Table 77. GC Pharma Company Information
Table 78. GC Pharma Introduction and Business Overview
Table 79. GC Pharma Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. GC Pharma Human Factor VIII Concentrate Product Offerings
Table 81. GC Pharma Recent Development
Table 82. Shanghai Raas Corp Company Information
Table 83. Shanghai Raas Corp Introduction and Business Overview
Table 84. Shanghai Raas Corp Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Shanghai Raas Corp Human Factor VIII Concentrate Product Offerings
Table 86. Shanghai Raas Corp Recent Development
Table 87. Hualan Biological Company Information
Table 88. Hualan Biological Introduction and Business Overview
Table 89. Hualan Biological Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Hualan Biological Human Factor VIII Concentrate Product Offerings
Table 91. Hualan Biological Recent Development
Table 92. Shandong Taibang Biological Products Company Information
Table 93. Shandong Taibang Biological Products Introduction and Business Overview
Table 94. Shandong Taibang Biological Products Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Shandong Taibang Biological Products Human Factor VIII Concentrate Product Offerings
Table 96. Shandong Taibang Biological Products Recent Development
Table 97. Shanghai Xinxing Medicine Company Information
Table 98. Shanghai Xinxing Medicine Introduction and Business Overview
Table 99. Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Shanghai Xinxing Medicine Human Factor VIII Concentrate Product Offerings
Table 101. Shanghai Xinxing Medicine Recent Development
Table 102. SinoCell Tech Company Information
Table 103. SinoCell Tech Introduction and Business Overview
Table 104. SinoCell Tech Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. SinoCell Tech Human Factor VIII Concentrate Product Offerings
Table 106. SinoCell Tech Recent Development
Table 107. CSL Company Information
Table 108. CSL Introduction and Business Overview
Table 109. CSL Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. CSL Human Factor VIII Concentrate Product Offerings
Table 111. CSL Recent Development
Table 112. Grifols Company Information
Table 113. Grifols Introduction and Business Overview
Table 114. Grifols Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Grifols Human Factor VIII Concentrate Product Offerings
Table 116. Grifols Recent Development
Table 117. Biogen Company Information
Table 118. Biogen Introduction and Business Overview
Table 119. Biogen Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Biogen Human Factor VIII Concentrate Product Offerings
Table 121. Biogen Recent Development
Table 122. Octapharma Company Information
Table 123. Octapharma Introduction and Business Overview
Table 124. Octapharma Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Octapharma Human Factor VIII Concentrate Product Offerings
Table 126. Octapharma Recent Development
Table 127. NovoNordisk Company Information
Table 128. NovoNordisk Introduction and Business Overview
Table 129. NovoNordisk Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. NovoNordisk Human Factor VIII Concentrate Product Offerings
Table 131. NovoNordisk Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Human Factor VIII Concentrate Downstream Customers
Table 135. Human Factor VIII Concentrate Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Factor VIII Concentrate Product Picture
Figure 2. Global Human Factor VIII Concentrate Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Human Factor VIII Concentrate Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Human Factor VIII Concentrate Sales Volume (2019-2030) & (K Units)
Figure 5. Global Human Factor VIII Concentrate Sales Price (2019-2030) & (US$/Unit)
Figure 6. Human Factor VIII Concentrate Report Years Considered
Figure 7. Global Human Factor VIII Concentrate Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Human Factor VIII Concentrate Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Factor VIII Concentrate Revenue in 2023
Figure 10. Human Factor VIII Concentrate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Blood Extraction Picture
Figure 12. Recombine Picture
Figure 13. Global Human Factor VIII Concentrate Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Human Factor VIII Concentrate Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Human Factor VIII Concentrate Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Human Factor VIII Concentrate Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Human Factor VIII Concentrate Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Congenital Coagulation Factor VIII Deficiency
Figure 19. Product Picture of Acquired Factor VIII Deficiency
Figure 20. Product Picture of Von Willebrand's Disease
Figure 21. Global Human Factor VIII Concentrate Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Human Factor VIII Concentrate Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Human Factor VIII Concentrate Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Human Factor VIII Concentrate Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Human Factor VIII Concentrate Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Human Factor VIII Concentrate Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Human Factor VIII Concentrate Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Human Factor VIII Concentrate Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Human Factor VIII Concentrate Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Human Factor VIII Concentrate Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Human Factor VIII Concentrate Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Human Factor VIII Concentrate Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Human Factor VIII Concentrate Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Human Factor VIII Concentrate Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Human Factor VIII Concentrate Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Human Factor VIII Concentrate Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Human Factor VIII Concentrate Sales Volume (%), (2019-2030)
Figure 38. United States Human Factor VIII Concentrate Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Human Factor VIII Concentrate Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Human Factor VIII Concentrate Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Human Factor VIII Concentrate Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Human Factor VIII Concentrate Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Human Factor VIII Concentrate Sales Value by Application (%), 2023 VS 2030
Figure 44. China Human Factor VIII Concentrate Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Human Factor VIII Concentrate Sales Value by Type (%), 2023 VS 2030
Figure 46. China Human Factor VIII Concentrate Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Human Factor VIII Concentrate Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Human Factor VIII Concentrate Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Human Factor VIII Concentrate Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Human Factor VIII Concentrate Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Human Factor VIII Concentrate Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Human Factor VIII Concentrate Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Human Factor VIII Concentrate Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Human Factor VIII Concentrate Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Human Factor VIII Concentrate Sales Value by Application (%), 2023 VS 2030
Figure 56. India Human Factor VIII Concentrate Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Human Factor VIII Concentrate Sales Value by Type (%), 2023 VS 2030
Figure 58. India Human Factor VIII Concentrate Sales Value by Application (%), 2023 VS 2030
Figure 59. Human Factor VIII Concentrate Industrial Chain
Figure 60. Human Factor VIII Concentrate Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
